Which are the causes of Ollier disease?

Ollier disease is a rare, non-hereditary skeletal disorder characterized by the growth of multiple benign cartilage tumors, known as enchondromas, within the bones. The primary cause is identified as a somatic mosaic mutation in the IDH1 or IDH2 genes, which occurs spontaneously after conception rather than being passed down from parents.

What causes Ollier disease?

At its core, Ollier disease is a condition of abnormal bone development. During early fetal development, cartilage cells that should normally harden into bone (ossification) fail to do so properly. Instead, these cells remain as nests of cartilage within the bone marrow space, forming tumors called enchondromas. Because Ollier disease typically affects only one side of the body or specific limbs, it is referred to as a "segmental" or "mosaic" condition, meaning only some cells in the body carry the genetic error while others do not.

Are there specific genetic mutations involved?

Medical research has confirmed that Ollier disease is driven by post-zygotic somatic mutations. This means the change occurs in a single cell after fertilization, and as that cell divides, the mutation is passed on to its "daughter" cells. Specifically, researchers have identified mutations in the IDH1 (isocitrate dehydrogenase 1) and IDH2 (isocitrate dehydrogenase 2) genes. These genes are responsible for producing enzymes that regulate cellular metabolism. When mutated, these enzymes produce an abnormal metabolite that disrupts normal bone growth and differentiation. It is important to note that because these mutations are somatic, Ollier disease is not considered an inherited or hereditary condition.

Is there a difference between causes and risk factors?

In the context of Ollier disease, the "cause" is the specific IDH1 or IDH2 mutation. There are no known environmental, dietary, or lifestyle "risk factors" that increase the likelihood of developing this condition. It is a stochastic (random) biological event. Unlike many other diseases where external factors might trigger an onset, Ollier disease occurs purely by chance during embryonic development. There is no evidence suggesting that parental health, medication use, or environmental exposures during pregnancy contribute to the development of the disorder.

What is the current state of research?

Current research into the etiology of Ollier disease is focused on understanding how IDH mutations alter the bone microenvironment. Scientists are currently exploring several key areas:

• Metabolic pathways: Investigating how the accumulation of the oncometabolite 2-hydroxyglutarate (2-HG) inhibits the normal maturation of chondrocytes (cartilage cells).


• Skeletal stability: Studying how to better manage the physical complications of Ollier disease, such as limb length discrepancy and pathological fractures.


• Malignant transformation: Researching the small percentage of patients who may develop secondary chondrosarcoma (a type of bone cancer) to identify early molecular markers for intervention.

The 279 members of the DiseaseMaps.org community living with Ollier disease highlight the importance of ongoing clinical surveillance, as the condition requires lifelong monitoring by orthopedists and oncologists to manage the potential for tumor progression or bone deformity.

Next steps

• Consult with a pediatric or adult orthopedic oncologist to establish a baseline for monitoring your enchondromas.


• Request a referral to a genetic counselor to discuss the somatic nature of IDH mutations and confirm that the condition is not hereditary.


• Join the DiseaseMaps.org community to connect with other patients and share experiences regarding management strategies.


• Maintain a consistent schedule of imaging (X-rays or MRIs) as recommended by your specialist to track any changes in bone health.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Ollier disease overview.


• Orphanet: Multiple enchondromatosis (Ollier disease) clinical entry.


• OMIM (Online Mendelian Inheritance in Man): Enchondromatosis, IDH1 and IDH2 mutations.


• PubMed: Recent clinical literature on IDH-mutant chondrogenic tumors.